Cambridge, United Kingdom

Stephanie Reikine

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Nuclera Ltd. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie Reikine. Retrieved from https://idiyas.com/inventor/stephanie-reikine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephanie Reikine

Introduction

Stephanie Reikine is a prominent inventor based in Cambridge, GB. She has made significant strides in the field of biotechnology, particularly in the area of protein expression. Her work has the potential to revolutionize how proteins are produced for various applications.

Latest Patents

Stephanie holds a patent for "Methods for cell-free protein expression." This patent discloses a method for the cell-free expression of peptides or proteins in a liquid-filled digital microfluidic device. The droplets containing the necessary components for cell-free protein expression can be manipulated by electrokinesis, enhancing the levels of protein expression within the droplets. She has 1 patent to her name.

Career Highlights

Stephanie is currently employed at Nuclera Ltd, where she continues to develop innovative solutions in protein expression technology. Her expertise and dedication to her field have positioned her as a key player in the biotechnology sector.

Collaborations

Throughout her career, Stephanie has collaborated with notable colleagues, including Michael Chun Hao Chen and Sihong Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Stephanie Reikine's contributions to the field of biotechnology, particularly in cell-free protein expression, highlight her role as an influential inventor. Her work at Nuclera Ltd and her innovative patent demonstrate her commitment to advancing scientific knowledge and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…